Medtronic and Cardinal Health already entered into exclusive talks over the medial supplies unit, and an official deal may be announced later this month, the source said.
The source also noted it’s possible negotiations do not result in a successful deal, according to the report.
Bloomberg broke news of Medtronic’s interest in divesting the unit, which sells everything from syringes to monitoring equipment, in early February. The sale would mainly offload assets Medtronic gained through its $42.9 billion acquisition of Covidien in 2014, according to the report.
Medtronic and Cardinal Health declined Reuter’s request for comment.
More articles on supply chain:
Arizona law OKs off-label drug promotion, contradicts FDA rules
Mallinckrodt drops out of PhRMA
FDA approves more drugs, faster than EU regulator: 4 findings
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
